Subject category:
Entrepreneurship
Published by:
Stanford Business School
Version: 6 February 2019
Length: 31 pages
Data source: Field research
Share a link:
https://casecent.re/p/163616
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
MedAvante, a provider of clinical trial services and technology solutions to the pharmaceutical industry, struggled to find product/market fit for many years, because its innovative service offering met fierce resistance from other stakeholders in the ecosystem. A strategic pivot to work with the ecosystem, not against it, saved the company and brought its co-founders to the brink of a successful exit. This case explores the difficulties of bringing innovation to a deeply conservative, highly regulated industry. It also analyzes the role that other stakeholders in a market ecosystem can play in encouraging, or blocking, the adoption of a star-tup's products/services.
Time period
The events covered by this case took place in 2019.Geographical setting
Region:
Americas
Country:
United States
About
Abstract
MedAvante, a provider of clinical trial services and technology solutions to the pharmaceutical industry, struggled to find product/market fit for many years, because its innovative service offering met fierce resistance from other stakeholders in the ecosystem. A strategic pivot to work with the ecosystem, not against it, saved the company and brought its co-founders to the brink of a successful exit. This case explores the difficulties of bringing innovation to a deeply conservative, highly regulated industry. It also analyzes the role that other stakeholders in a market ecosystem can play in encouraging, or blocking, the adoption of a star-tup's products/services.
Settings
Time period
The events covered by this case took place in 2019.Geographical setting
Region:
Americas
Country:
United States